SCHEMBL5690020

SCHEMBL5690020

COc1nc(Nc2ccc(F)c(Cl)c2)c2cc(OCCCN3CCOCC3)c(C3CC3)cc2n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.65
▸ ERBB2 P04626 4/20 0.65
▸ BRAF P15056 2/20 0.65
▸ CIT O14578 2/20 0.65
▸ GAK O14976 2/20 0.65
▸ EPHB6 O15197 2/20 0.65
▸ RIPK2 O43353 2/20 0.65
▸ STK17B O94768 2/20 0.65
▸ STK10 O94804 2/20 0.65
▸ ABL1 P00519 2/20 0.65
▸ LCK P06239 2/20 0.65
▸ LYN P07948 2/20 0.65
▸ RET P07949 2/20 0.65
▸ MET P08581 2/20 0.65
▸ HCK P08631 2/20 0.65
▸ FGR P09769 2/20 0.65
▸ KIT P10721 2/20 0.65
▸ SRC P12931 2/20 0.65
▸ EPHA1 P21709 2/20 0.65
▸ ERBB3 P21860 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12474212 0.84 EGFR (0.64) EGFRERBB2BRAFCITGAK
SCHEMBL5040071 0.81 EGFR (0.61) EGFRERBB2BRAFCITGAK
Gefitinib SCHEMBL29351046 0.79 EGFR (1.00) EGFRERBB2BRAFCITGAK
SCHEMBL1734701 0.79 EGFR (1.00) EGFRERBB2BRAFCITGAK
Gefitinib SCHEMBL7866 0.79 EGFR (1.00) EGFRERBB2BRAFCITGAK
Gefitinib SCHEMBL29351336 0.79 EGFR (1.00) EGFRERBB2BRAFCITGAK
Gefitinib SCHEMBL465143 0.79 EGFR (1.00) EGFRERBB2BRAFCITGAK
SCHEMBL27595565 0.79 RAF1 (0.46) EGFRERBB2BRAFERBB3KDR
SCHEMBL2163611 0.78 EGFR (0.81) EGFRERBB2BRAFCITGAK
Gefitinib SCHEMBL2770155 0.78 EGFR (0.98) EGFRERBB2BRAFCITGAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1521595-B1 NOVEL DRUG COMPOSITIONS BASED ON NOVEL ANTICHOLINERGICS AND INHIBITORS OF EGFR-KINASE BOEHRINGER INGELHEIM PHARMA (DE) 2006-03-15 — — EP claimed
Send feedback